Key Drivers
- Strong liquidity
- Persistent losses
- Weak efficiency
AIAI Summary
SDGR is shifting from a “growth optionality” story to a turnaround that must prove it can convert sticky software demand and a strong cash cushion into margin expansion and free cash flow, because the latest miss, negative EBITDA, and weak stock trend show investors are now paying for execution rather than the narrative.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong liquidity
- •Persistent losses
- •Weak efficiency
SDGR has a strong cash-rich balance sheet and solid near-term liquidity, but persistent losses, shrinking margins, and weak efficiency continue to dominate the investment case.
Price Behavior
Key Price Behavior Insights:
- •Momentum fade
- •Resistance overhead
- •Support at risk
SDGR rallied to a last month high near $13.28 but quickly faded to $11.95, leaving near-term momentum bearish with $12.30–$12.60 as resistance and $11.74 as key support.
Sharp pullback from the last month high near $13.28 to $11.95 signals short-term selling pressure
Sentiment & News
Key News Insights:
- •Earnings miss
- •Insider selling
- •Investor outreach
Schrödinger entered its Q1 2026 earnings period with insider activity and investor updates, but the report disappointed as it posted a wider-than-expected loss and missed revenue estimates, weighing on shares.
The weak Q1 results and prior share pressure suggest near-term downside risk, though ongoing conference participation may help maintain investor visibility
Similar Companies in Healthcare
Other companies in the same sector with AI ratings